Managing Risks with Immune Therapies in Multiple Sclerosis

Overview of attention for article published in Drug Safety, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 14,396 followers.

RT @OhioHealthMS: Managing Risks with Immune Therapies in Multiple Sclerosis. - PubMed - NCBI https://t.co/Je7OQscJj2

Managing Risks with Immune Therapies in Multiple Sclerosis. - PubMed - NCBI https://t.co/Je7OQscJj2

Managing Risks with Immune Therapies in Multiple Sclerosis. https://t.co/6zgSdmZd08

RT @CheloXPtw: Seguridad de los medicamentos para la esclerosis múltiple: revisión en Drug Safety https://t.co/svY0bF7W9k https://t.co/Ewlx…

Seguridad de los medicamentos para la esclerosis múltiple: revisión en Drug Safety https://t.co/svY0bF7W9k https://t.co/EwlxyMjAhv